ALX Oncology ALXO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 1.67 | 106.53 | -0.53 | -30,613 | -29 | |
| 2024Q3 | 1.82 | 107.62 | -0.58 | -32,567 | -31 | |
| 2024Q2 | 6.03 | 106.56 | -0.76 | -41,525 | -39 | |
| 2024Q1 | 11.15 | 107.42 | -0.71 | -37,762 | -36 | |
| 2023Q4 | 14.89 | 106.58 | -0.92 | -48,023 | -45 | |
| 2023Q3 | 4.80 | 105.29 | -1.25 | -53,275 | -51 | |
| 2023Q2 | 7.51 | 108.85 | -0.83 | -36,777 | -34 | |
| 2023Q1 | 4.52 | 108.07 | -0.74 | -32,203 | -30 | |
| 2022Q4 | 11.27 | 105.11 | -0.75 | -32,219 | -31 | |
| 2022Q3 | 9.57 | 103.84 | -0.87 | -36,681 | -35 | |
| 2022Q2 | 8.09 | 102.63 | -0.81 | -33,789 | -33 | |
| 2022Q1 | 16.90 | 100.87 | -0.60 | -24,747 | -25 | |
| 2021Q4 | 21.49 | 100.09 | -0.70 | -28,472 | -28 | |
| 2021Q3 | 73.86 | 100.08 | -0.61 | -24,576 | -25 | |
| 2021Q2 | 54.68 | 100.19 | -0.41 | -16,299 | -16 | |
| 2021Q1 | 73.74 | 100.18 | -0.35 | -14,208 | -14 | |
| 2020Q4 | 86.20 | 96.66 | -0.09 | -17,825 | -19 | |
| 2020Q3 | 37.74 | 98.88 | 4.11 | -9,809 | -10 | |
| 2020Q2 | -0.40 | -10,787 | -11 | |||
| 2020Q1 | -0.24 | -5,242 | -5 |